Skip to content

Clinical trials

Phase 2 Lymphoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 2 Country / region: Germany Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20045
20053
20062
20073
20082
20093
20113
20122
20131
20141
20162
20173
20183
20191
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated4
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Incyte Corporation3
University of Cologne3
Bristol-Myers Squibb2
Janssen Research & Development, LLC2
ADC Therapeutics S.A.1
Amgen Research (Munich) GmbH1
Bayer1
BioCryst Pharmaceuticals1
CTI BioPharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma40
Lymphoma, Non-Hodgkin12
Lymphoma, Large B-Cell, Diffuse6
Lymphoma, T-Cell, Cutaneous6
Hodgkin Disease5
Recurrence5
Lymphoma, Follicular4
Lymphoma, Mantle-Cell4
Mycosis Fungoides3
Burkitt Lymphoma2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.